Obesity Care

Beyond BMI: A new framework for diagnosing obesity with a focus on overall health

The traditional method of diagnosing and managing obesity, which heavily relies on body mass index (BMI), is increasingly seen as inadequate. Acknowledging this, the European Association for the Study of Obesity (EASO) has introduced a comprehensive new framework for diagnosing, staging, and managing adult obesity. Detailed in a recent publication in Nature Medicine, this framework aims to incorporate the latest scientific insights and advancements, including novel obesity medications, to ensure more effective and inclusive treatment strategies.

Obesity is widely recognised as a multifactorial, chronic, relapsing, non-communicable disease characterised by an abnormal and/or excessive accumulation of body fat. Traditionally, the diagnosis has been predominantly based on BMI cut-off values. This method fails to consider critical factors such as the distribution and functional roles of adipose tissue in the disease’s severity.

The EASO Steering Group, comprising current and former association presidents among other experts, has crafted a series of statements that update the obesity management approach to reflect the latest scientific knowledge. A key update in this new framework is the revised approach to the anthropometric component of obesity diagnosis. The authors explain, “An important novelty of our framework regards the anthropometric component of the diagnosis. The basis for this change is the recognition that BMI alone is insufficient as a diagnostic criterion, and that body fat distribution has a substantial effect on health.” They specifically highlight the health risks associated with the accumulation of abdominal fat, noting its association with an increased risk of cardiometabolic complications and its significance as a determinant of disease, even in individuals with a BMI below traditional obesity thresholds.

The new framework underscores the importance of considering abdominal (visceral) fat accumulation as a critical health risk factor, even in individuals with lower BMI (≥25–30 kg/m^2) who exhibit significant abdominal fat but may lack overt clinical symptoms. This broader definition aims to reduce the risk of undertreating these individuals compared to the current BMI-based criteria.

Treatment recommendations within the framework align with existing guidelines but emphasise behavioural changes such as dietary adjustments, increased physical activity, stress management, and improved sleep quality. Psychological therapy, obesity medications, and metabolic or bariatric procedures are also considered crucial, depending on individual needs.

The steering committee has pointed out that the traditional reliance on BMI cut-offs in clinical trials and guidelines often excludes individuals who, despite having a lower BMI, carry a significant obesity-related health burden. The committee suggests a shift towards including patients with a BMI of at least 25 kg/m^2 and a waist-to-height ratio above 0.5, who also exhibit medical, functional, or psychological impairments, in obesity medication and treatment programmes.

The authors make a call to action to pharmaceutical companies and regulatory bodies: “This statement may also be seen as a call to pharmacological companies and regulatory authorities to use inclusion criteria that are more adherent to the clinical staging of obesity and less to traditional BMI cut-offs when designing future clinical trials with obesity medications.”

In conclusion, the authors advocate for a paradigm shift in obesity management, likening it to the management of other chronic non-communicable diseases. They emphasise the importance of defining long-term, personalised therapeutic goals from the outset of treatment, considering the disease’s stage and severity, therapeutic options, side effects, patient preferences, and individual challenges. They stress the necessity for a comprehensive, life-long treatment plan over mere short-term weight reduction, stating, “Emphasis on the need for a long-term or life-long comprehensive treatment plan rather than short-term body weight reduction is warranted.”

Research highlights how lifestyle can overcome genetic obesity risks

A groundbreaking study published in “Cell Metabolism” has illuminated the powerful role of lifestyle modifications in mitigating the genetic predisposition to obesity, revealing new avenues for managing this global health challenge.

Obesity has reached pandemic proportions, exacerbated by inactive lifestyles and the consumption of high-calorie diets. The condition is influenced by both heritable and polygenic factors, with numerous metabolic pathways and over a thousand genetic variants playing roles. Traditionally, it was assumed that one’s genetic risk for obesity was unalterable.

Recent gene-environment studies have hinted that certain lifestyle choices might lessen the influence of specific genes linked to obesity. These studies, however, typically focused only on limited genes and lifestyle factors, leaving a gap in understanding the broader interaction between lifestyle habits and genetic predispositions.

This latest research delved into whether lifestyle changes could indeed counteract genetic risks. The study cohort included 338,600 white British participants from the UK Biobank, refined to 337,554 after excluding those lacking essential data. Researchers calculated a polygenic score (PGS) from a genome-wide association study on body mass index (BMI) specific to individuals of European descent. They also developed a healthy lifestyle score based on five factors: alcohol consumption, sleep duration, sedentary behaviour, diet, and physical activity. The study’s primary focus was on new obesity cases, with existing obesity cases as a secondary focus.

The researchers predicted absolute risks using odds ratios (ORs) and hazard ratios (HRs) for both new and existing obesity, relative to PGS percentile and lifestyle factors. These ratios were derived from Cox proportional hazard and logistic regression models. They also calculated the probability of developing obesity by age 75 and identified new obesity-related morbidities (ORMs) from various health data sources.

Analyses showed that high genetic risk and unhealthy lifestyle habits were each linked to higher obesity risks, both independently and combined. The risk was most pronounced in those with both high genetic predisposition and poor lifestyle habits, with a HR of 3.54 compared to those with low genetic risk and healthy lifestyles.

Interestingly, the median likelihood of obesity by age 75 varied significantly with lifestyle: 2.8% in those with poor lifestyles versus 1.7% in those with healthier choices. This pattern was echoed in the analysis of existing obesity cases.

The study also found significant additive interactions between lifestyle and genetic risk in terms of obesity incidence, with consistent results from multiplicative interaction analysis. Importantly, sedentary behaviour was linked to the highest obesity risk, regardless of genetic background. Conversely, individuals with high genetic risk but who maintained healthy lifestyles had similar ORMs to those with lower genetic risk.

Overall, the study underscores the profound impact of healthy lifestyle choices in reducing the risk of obesity and its related health issues, even among those with a high genetic predisposition. These findings advocate for the promotion of active, health-conscious behaviours across all genetic backgrounds as a critical strategy in combating obesity.

This research not only challenges the fatalistic view of genetic determinism but also highlights the empowering role of personal lifestyle choices in managing one’s health.

New research highlights the obesity-fighting properties of the ketogenic diet

A groundbreaking study recently published in Nature Metabolism has uncovered the protective effects of bile acids (BAs) induced by the ketogenic diet (KD) in the fight against obesity.

Obesity is linked to a myriad of health issues including cardiovascular diseases, cancer, diabetes, and non-alcoholic fatty liver disease. These associations underscore the urgent need for effective treatments to alleviate its extensive health impacts.

The ketogenic diet, recognised for its distinctive metabolic effects, has been proven beneficial in managing refractory epilepsy and other health disorders. Research indicates that changes in gut microbiota and metabolites might play a role in the diet’s protective properties against intestinal inflammation and seizures.

Although it’s clear that gut microbiota and metabolites are pivotal in the metabolic transformations elicited by KD in both rodents and humans, the specific microbes and metabolites responsible remain unidentified.

In the referenced study, the efficacy of KD in obesity prevention was demonstrated through an experimental setup involving mice. These mice were fed either a standard chow diet (CD) or a KD for seven weeks. Results indicated significant reductions in fasting glucose levels and body weight in those on KD. Metabolomics analysis further identified shifts in the metabolic profiles of the KD group, with increases in 22 metabolites and decreases in 18.

A subsequent experiment involved feeding mice with CD, KD, or a methionine-supplemented version of KD (KDM) over seven weeks. The addition of methionine to KD reversed the diet’s reductions in glucose levels and body weight and decreased six taurine-conjugated bile acids in serum. KD alone reduced levels of certain unconjugated BAs, which were restored by KDM.

When gut microbiota were depleted, differences in body weight and glucose levels between KD and KDM groups vanished, highlighting the role of microbiota in these effects. Faecal microbiota transplantation (FMT) from KD-fed to CD-fed mice resulted in weight loss and enhanced glucose tolerance. Conversely, FMT from KDM mice had no significant impact.

Further analyses showed that KD reduced the alpha diversity of gut microbiota, a change reversed by KDM. This diet also affected specific bacterial strains, which were restored by KDM supplementation. Studies on energy absorption revealed that KD-fed mice exhibited higher faecal energy content, suggesting a reduction in calorie absorption.

RNA sequencing of ileal tissues indicated that treatment with specific bile acids (TUDCA or TDCA) downregulated CAR1, a gene associated with obesity. These treatments also diminished lipid accumulation in cells, facilitated weight loss, and decreased intestinal lipid absorption in mice.

In models of diabetes and obesity, treatments with TUDCA and TDCA resulted in weight reduction, lower fasting glucose levels, improved glucose tolerance, and decreased liver fat. Human studies paralleled these findings, showing that lower plasma levels of certain conjugated BAs were associated with higher body mass index and fasting glucose levels.

In conclusion, this study illuminates the potential of the ketogenic diet and targeted bile acid treatments in managing obesity and improving metabolic health through modifications in gut microbiota and metabolic processes.

The findings highlight critical host-gut microbiota interactions and support the use of TUDCA and TDCA as potential therapeutic agents for tackling obesity and its associated complications.

Natural compound found in olives shown to lower blood sugar and aid weight loss, mouse study shows

A novel study conducted using mice models has highlighted the potential of elenolic acid, a natural compound extracted from olives, in mitigating obesity and type 2 diabetes. This groundbreaking research suggests that elenolic acid could serve as a basis for the development of affordable, safe natural products aimed at managing these prevalent health issues.

In a series of experiments, diabetic mice with obesity administered with elenolic acid orally displayed a significant reduction in body weight and enhanced glucose regulation within just one week. These results were noteworthy when compared to a control group of mice with obesity that did not receive the treatment. Remarkably, the glucose-lowering impact of elenolic acid was on par with liraglutide, an injectable diabetes medication, and surpassed the effectiveness of metformin, a commonly used oral diabetes drug.

Professor Dongmin Liu, the lead researcher and a professor at the Department of Human Nutrition, Foods and Exercise at Virginia Tech, explained the motivation behind their focus on natural compounds. “Lifestyle modifications and public health measures have had limited impact on the rising prevalence of obesity, one of the top risk factors for type 2 diabetes. Available obesity drugs are ineffective in weight loss maintenance, expensive and/or carry potential long-term safety risks. Our goal was to develop safer, cheaper and more convenient multi-targeting agents that can prevent the occurrence of metabolic disorders and type 2 diabetes,” stated Liu.

The research findings will be presented by Dr. Hana Alkhalidy, a scientist in Liu’s laboratory, at NUTRITION 2024, the premier annual event of the American Society for Nutrition.

The team at Virginia Tech has previously investigated various natural compounds targeting molecular aspects of metabolism in critical body parts like the pancreas, muscle, fat tissues, and liver. Their latest strategy focuses on stimulating hormone secretion in the gut, a method that could indirectly improve metabolic functions due to natural products’ generally poor bioavailability.

Their screening identified that elenolic acid, found abundantly in mature olives and extra virgin olive oil, stimulates the release of metabolic hormones GLP-1 and PYY in the gut. These hormones are integral during meals, enhancing satiety and regulating blood sugar and metabolism. The researchers synthesized elenolic acid from its precursor, oleuropein, which proved to be a cost-effective method compared to direct extraction from olives.

Further testing revealed that diabetic mice with obesity treated with elenolic acid for four to five weeks showed a 10.7% reduction in obesity and exhibited glucose levels and insulin sensitivity comparable to healthy, lean mice. Additionally, the treatment significantly curbed food intake and fostered weight loss, effects associated with increased levels of PYY and GLP-1 and decreased expression of agouti-related peptide, a hypothalamic peptide that promotes overeating and weight gain when overexpressed.

“Overall, the study showed that elenolic acid from olives has promising effects on hormone release and metabolic health, particularly in obese and diabetic conditions,” Liu remarked. He noted that the compound mimics the physiological conditions of eating to enhance gut metabolic hormone secretion, thereby helping to regulate energy balance and metabolic health.

Despite these promising results, the researchers cautioned that the concentration of elenolic acid in typical olive products is quite low, implying that the health benefits observed in the study are unlikely to be replicated through consumption of olives and olive oil alone.

The research team is now focused on elucidating the metabolic pathway of elenolic acid, from its absorption to its excretion. This exploration will provide further insights into the compound’s efficacy and safety, paving the way for potential clinical trials.

Findings suggest exposure to greenspace Is linked to lower risk of obesity-related cancer

A comprehensive study led by the University of Queensland has established a connection between regular exposure to greenspace and a decreased risk of obesity-related cancers. This pivotal research, spearheaded by PhD candidate Chinonso Odebeatu from the university’s School of Public Health, involved an extensive analysis of data pertaining to nearly 280,000 individuals, aged between 37 and 73, residing in England, Scotland, and Wales, who were recruited from 2006 to 2010.

“The large-scale biomedical database, Biobank UK, was utilised for the study, and we determined the greenspace around participants’ homes using the Ordnance Survey MasterMap Greenspace dataset,” explained Mr. Odebeatu. He further elaborated on the intent behind the study: “Our focus was on how greenspace might affect specific health outcomes, which led us to link the data to the UK’s National Cancer Registry.”

The findings were significant. Of the 279,000 participants, nearly 10,000 developed obesity-related cancers over an eight-year follow-up period. Mr. Odebeatu noted, “When we examined the type and quantity of greenspace around the participants, we discovered that exposure to a private residential garden was associated with a reduced risk of developing cancers, notably breast and uterine cancer.”

The study suggests that having greenspace nearby encourages physical activity, increases opportunities for Vitamin D synthesis, and might even mitigate the effects of air pollution. Mr. Odebeatu pointed out that the health benefits of access to a household garden were more pronounced among specific groups, including women, non-smokers, and individuals who abstain from alcohol.

“It was also more beneficial for individuals who were physically active, those without cardiovascular issues, and those not suffering from vitamin D deficiencies,” he added.

Associate Professor Nicholas Osborne, also from the University of Queensland’s School of Public Health, emphasised the broader implications of these findings. “These results support policies and initiatives that aim to increase people’s access to greenspace. We know living in areas with abundant greenspace can positively impact both physical and mental health and well-being,” Dr. Osborne stated.

He suggested that the study not only deepens understanding of the health benefits of greenspace but also underscores the importance of community gardens for those without access to private gardens. “Encouraging outdoor activities and ensuring adequate vitamin D levels could further amplify these benefits,” Dr. Osborne concluded.

This groundbreaking research was published in the journal Science of The Total Environment, highlighting the potential of greenspaces in combating obesity-related cancers and enhancing public health.

Nuts can aid in weight loss efforts, research shows

Nuts, often enjoyed as a topping on morning cereal or as a mid-afternoon nibble, may play a pivotal role in effective weight management strategies, according to new research findings.

A study conducted by the University of South Australia has found that nuts can be a beneficial component of calorie-restricted diets aimed at weight loss. The research, which synthesised data from seven randomised controlled trials, assessed the impact of nut inclusion on weight loss and glycemic control within energy-restricted (ER) diets. The findings indicated that including nuts did not negatively affect weight loss outcomes; on the contrary, it may enhance them.

The analysis revealed that in four out of the seven studies, participants who incorporated between 42 to 84 grams of nuts daily into their ER diets experienced significantly greater weight loss—ranging from an additional 1.4 to 7.4 kilograms—compared to those on similar diets without nuts. This weight loss benefit is thought to stem from nuts’ ability to effectively suppress appetite.

In instances where no discernible difference in weight loss was observed between nut-enriched and nut-free diets, the quantity of nuts included in the diets was generally lower.

This research arrives amidst concerning statistics from the Australian Bureau of Statistics, which indicate that 67% of Australian adults are either overweight or obese. Thus, the study’s insights are particularly timely and relevant.

Professor Alison Coates from UniSA highlighted the nutritional value of nuts, advocating for their inclusion in weight-loss diets. “Many people shun nuts in their diet due to the misconception that their high energy and fat content contribute to weight gain,” Professor Coates explained. However, she clarified that nuts are abundant in healthy unsaturated fats, plant proteins, and dietary fibre, all of which aid in promoting fullness and reducing overeating. She also noted nuts’ association with improved cardiovascular health, better gut health, and enhanced cognitive function.

Despite these benefits, it appears that nut consumption among Australians is less than ideal, with 60% of the population reporting they do not consume any nuts at all.

Professor Coates reassured that, contrary to common fears, nuts do not promote weight gain. “If concerns about weight gain have been deterring people from consuming nuts, they need not worry. Nuts do not lead to weight gain and seem to actually support weight loss efforts,” she asserted.

Dr Sharayah Carter, a co-author of the study, also celebrated the findings. She emphasised the unique flavour and texture profile of nuts, which make them an integral part of many diets, and highlighted their convenience as a healthy snack option. “For those who enjoy nuts, it is heartening to know that they can contribute to achieving weight-loss objectives while also enhancing overall health,” Dr Carter said. She added that health professionals should feel confident in recommending nuts as part of a healthy diet, with no adverse effects on weight management.

This study underscores the role of nuts as a beneficial addition to weight loss diets, helping to debunk myths about their dietary impact while promoting their numerous health advantages.

Evening workouts best for lowering blood sugar in adults with overweight and obesity

Recent investigations have shown that exercising in the evening can significantly decrease daily blood sugar levels in inactive adults who have overweight or obesity. This finding was reported in a study published in the journal Obesity, the flagship publication of The Obesity Society (TOS).

The study reveals that while the benefits of moderate to vigorous physical activity on glucose homeostasis are well acknowledged for adults at increased risk of insulin resistance, the specific timing that maximises these benefits had not been determined until now.

Professor Jonatan R. Ruiz of the University of Granada, who specialises in physical activity and health within the Faculty of Sport Sciences-Sport and Health University Research Institute (iMUDS), underscored the significance of timing in exercise routines. “Our results highlight the importance of the field of precision exercise prescription. In clinical practice, certified sports and medical personnel should consider the optimal timing of the day to enhance the effectiveness of the exercise and physical activity programmes they prescribe,” stated Ruiz. He led the research alongside predoctoral researcher Antonio Clavero-Jimeno.

The research utilised baseline data from a multi-centre randomised controlled trial carried out in Granada and Pamplona, Spain. The study aimed to examine the impact of time-restricted eating on visceral adipose tissue, body composition, and cardiometabolic risk factors among adults with obesity and overweight.

Involving 186 participants with an average age of 46 years and a body mass index of 32.9 kg/m2, the study monitored physical activity and glucose levels simultaneously over a 14-day period. This was achieved using a triaxial accelerometer and a continuous glucose-monitoring device.

Researchers categorised the volume of physical activity into periods: morning, afternoon, and evening. Activities were assigned to a period if over 50% of exercise was done within those times, with evening defined as 6 p.m. to midnight.

The findings indicated that engaging in more than 50% of daily moderate to vigorous physical activity in the evening led to lower glucose levels throughout the day and night, and these benefits were particularly pronounced in individuals with impaired glucose regulation. This pattern was consistent across both genders.

Renee J. Rogers, PhD, a senior scientist at the University of Kansas Medical Center, highlighted the implications for tailored exercise advice. “As the field moves towards individualised exercise prescriptions for different chronic conditions, this study now provides additional insights beyond just telling patients to ‘move more,’ but instead to move as often as possible and to prioritise afternoon-to-evening movement when feasible for glucose regulation,” said Rogers, who was not involved in the study.

The study also featured contributions from Manuel Dote-Montero, Jairo H. Migueles, Alba Camacho-Cardenosa from the University of Granada; Maddi Oses, Jon Echarte Medina, Juan M.A. Alcantara, Idoia Labayen from the Public University of Navarre and the Navarra Institute for Health Research (ldiSNA), and Manuel Muñoz-Torres from ibs.GRANADA and the University Hospital San Cecilio Clinic.

In-depth study unveils complex impact of obesity and metabolic syndrome on breast cancer risk

Recent research led by a University of Oklahoma academic has identified nuanced relationships between obesity, metabolic syndrome, and breast cancer risks, potentially guiding better preventative strategies for at-risk patients. The comprehensive findings stem from the Women’s Health Initiative (WHI), an extensive study initiated in the early 1990s focused on postmenopausal women’s health issues, including cancer, cardiovascular diseases, and osteoporosis.

Robert Wild, M.D., Ph.D., a professor of obstetrics and gynaecology at the OU College of Medicine, and a longstanding contributor to the WHI, co-authored this pivotal study published in the journal Cancer of the American Cancer Society. This investigation is part of a series of outputs from the WHI, which remains the largest preventative health study on women. It builds on previous research which demonstrated that a low-fat diet could reduce breast cancer mortality by 21% over two decades, prompting further exploration into whether this benefit was due to reduced obesity levels or amelioration of metabolic syndrome symptoms.

Dr. Wild elaborated on the study’s findings, stating, “This study shows that obesity had an effect on breast cancer independent of metabolic syndrome, and that metabolic syndrome had an effect on breast cancer independent of obesity. And they affected various subtypes in different ways, which influenced whether women were diagnosed with breast cancer and whether they died from it.”

The study’s insights are multifaceted: it confirms the importance of managing both body weight and metabolic health to mitigate breast cancer risks. Dr. Wild emphasised the foundational health practices, remarking, “This study is essentially saying to get back to the basics. Prevention is important, and we need to be paying attention to both metabolic syndrome and weight.” Metabolic syndrome comprises a cluster of conditions—elevated blood pressure, high blood sugar, excess abdominal fat, and abnormal cholesterol or triglyceride levels—all of which also heighten the risk of cardiovascular disease and diabetes.

In more detailed findings, the study reported:

• Metabolic syndrome is significantly associated with a 53% increase in deaths post-breast cancer diagnosis and a 44% rise in breast cancer mortality rates.
• The syndrome adversely affects prognosis specifically in cases of oestrogen receptor (ER)-positive and progesterone receptor (PR)-negative breast cancers.
• ER-positive cancers, which constitute 70-80% of all breast cancer cases, are typically hormone-dependent for growth and generally respond to hormone therapy.
• Conversely, PR-negative cancers lack hormone receptors, do not benefit from hormone therapies, and often exhibit faster growth compared to hormone-positive cancers.
  

The research also highlighted obesity’s impact, noting a higher incidence of breast cancer and mortality rates particularly among women with severe obesity. However, obesity showed a correlation with better outcomes in ER-positive and PR-positive cancers, which are treatable with hormone therapy and generally have a slower growth rate.

Dr. Wild reflected on the lasting value of the WHI data, saying, “The Women’s Health Initiative is the gift that keeps on giving. It is a great opportunity to make use of quality information. In the beginning, I don’t think we knew what a valuable resource it would still be years later.”

This study not only underscores the complex interactions between obesity, metabolic syndrome, and breast cancer but also reinforces the critical need for integrated health strategies to address these risks comprehensively.

Significant link between obesity and cognitive decline revealed by Chinese research

A recent study conducted in China has established a significant connection between obesity and the deterioration of brain health, suggesting that individuals with obesity may suffer from a reduction in brain volume akin to the effects seen after 12 years of ageing.

Researchers from Tsinghua University and Capital Medical University Affiliated Beijing Friendship Hospital undertook a comprehensive study spanning 16 years, during which they monitored the body mass index (BMI) and brain health of over 1,000 Chinese adults across various age groups. The findings of this research were derived from neuroimaging data, which highlighted a distinct association between obesity and several markers of cognitive decline. These markers include diminished brain volume, an increase in white matter lesions, and compromised microstructural integrity of the brain.

In the context of China’s health standards, an individual with a BMI exceeding 24 is categorised as having overweight, and obesity is defined at a BMI threshold of 28. The study, published in the journal Health Data Science, notes a critical finding: individuals under the age of 45 with a BMI over 26.2 exhibit brain volume reductions equivalent to the natural age-related decline observed over 12 years.

This research was spotlighted by the state media outlet Life Times, which stressed the study’s recommendation for younger individuals to maintain a BMI below 26.2 to safeguard their cognitive health. The report emphasised the absence of health benefits in being overweight, stating, “There is no healthy overweight person.”

The implications of obesity on brain health are not unique to China. A related study published in 2023 by a Lancet sub-journal, involving 10,000 participants from across Asia, corroborated these findings. This study illustrated that an increase of 0.27 kilograms in visceral fat correlates with 0.7 years of cognitive ageing for the average person.

Concerns are growing regarding the future health landscape of the Asia-Pacific region, as the authors of the study forecast a surge in dementia cases coinciding with increasing obesity levels and an ageing population. The region, which currently sees approximately 4 million new dementia cases annually—accounting for 40% of the global incidence—is also witnessing a rise in obesity rates that surpass the global average by about 7%.

A separate 2023 study, encompassing nearly 15.8 million adults from more than 240 Chinese cities, reported that 34.8% of the subjects had overweight and 14.1% were classified as having obesity. The study further noted a higher propensity for obesity and overweight conditions among men compared to women, with affected individuals more likely to suffer from health issues such as fatty liver disease, prediabetes, and hypertension.

Sun Dejin, a neurologist from Shenzhen Third People’s Hospital, shared insights with Life Times regarding the severe impact of obesity on cognitive functions. According to Sun, obesity leads to notable cognitive impairments, including deteriorations in thinking, learning, and memory capabilities. He warned that if these cognitive declines are not addressed, they could progress to dementia, posing severe risks to overall health and well-being.

This body of research collectively underscores the critical need for managing obesity to mitigate its profound effects on brain health and cognitive function.

Research reveals fathers’ diet affects child health before birth

A pioneering study conducted by Helmholtz Munich and the German Center for Diabetes Research has shed new light on the significant influence of paternal diet and body mass on the health of future generations even before conception occurs. This groundbreaking research offers vital insights that could lead to the development of targeted preventive health strategies for men planning to father children. The crux of the findings suggests a direct correlation between a father’s nutritional habits and the reduced risk of offspring developing metabolic conditions such as obesity and diabetes in later life.

Dr. Raffaele Teperino, who leads the Environmental Epigenetics research group at Helmholtz Munich, spearheaded this inquiry along with his team. Their research primarily focused on mitochondrial tRNA fragments (mt-tsRNAs) present in sperm, which are crucial in the epigenetic transmission of health characteristics, effectively regulating gene expression that impacts the health trajectory of children.

The empirical evidence was derived from the LIFE Child cohort data, encompassing over 3,000 families. Analysis from this cohort illustrated a clear link between paternal body mass and children’s propensity towards obesity and metabolic diseases, a connection that remains irrespective of maternal weight, genetic factors, or environmental influences.

To corroborate these findings, Dr. Teperino’s team undertook experimental studies on mice. These experiments involved feeding mice a high-fat diet and observing the resultant effects on their reproductive systems, particularly focusing on the epididymis where sperm matures. The findings were striking: offspring of mice fed a high-fat diet exhibited a marked increase in susceptibility to metabolic diseases.

Further laboratory studies involved creating embryos via in-vitro fertilisation using sperm from these diet-affected mice. Remarkably, mt-tsRNAs from the sperm of high-fat diet mice were detected in the early stages of these embryos, significantly altering gene expression which, in turn, influenced the development and health of the resulting offspring.

Professor Martin Hrabě de Angelis, co-author and Research Director at Helmholtz Munich, emphasised the importance of these findings: “Our research confirms that acquired phenotypes, like diabetes and obesity, can be epigenetically transmitted across generations. This underscores epigenetics as a molecular bridge that connects environmental factors with genetic frameworks across generational lines, a process evident not only through maternal lineage but, importantly, through paternal contributions as well.”

This research underscores the critical role of paternal health in the pre-conception phase and presents a compelling case for enhanced preventive health strategies targeting prospective fathers. These strategies, particularly focused on dietary guidance, could significantly mitigate the risk of obesity and diabetes in children, enhancing generational health outcomes.

The study also touches on the broader implications concerning mitochondrial functions. Commonly recognized as cellular powerhouses, mitochondria possess their own DNA (mt-DNA), which orchestrates protein production within mitochondria through mt-RNA and is traditionally inherited maternally. This research brings to light the lesser-known fact that fathers also contribute mt-tsRNAs during fertilisation, which play a role in the epigenetic regulation of gene expression in early embryos. This epigenetic influence by paternal mt-tsRNAs not only underscores their role in shaping the mitochondrial function but also highlights their indirect yet pivotal influence on the metabolic health of their children.

The link between chilli pepper consumption and increased obesity risk

In a detailed study published in Frontiers in Nutrition, researchers investigated the association between the frequency of chilli pepper consumption and the risk of developing obesity. The research used comprehensive data from the 2003-2006 National Health and Nutrition Examination Survey (NHANES), which gathers extensive demographic, health, and nutritional information from various age groups and ethnicities across the U.S.

The study involved 6,138 participants, whose chilli intake frequencies were documented through a food frequency questionnaire. Participants were divided into three groups: those who reported no chilli intake, occasional chilli intake, and frequent chilli intake. The researchers used participants’ height and weight data to calculate BMI, considering a BMI of 30 kg/m^2 or more as having obesity. They also examined a broad range of socio-demographic and lifestyle characteristics as covariates in the analysis.

Results from the questionnaire indicated that 16.8% of the study population reported no chilli intake, 74% had occasional chilli intake, and 9.2% had frequent chilli intake. In terms of lifestyle risk factors related to obesity, percentages of participants reporting current smoking habits, alcohol consumption, hypertension, and diabetes were noted respectively.

The analysis did not initially find significant differences in BMI across the three chilli consumption groups. However, a significant positive correlation emerged between the frequency of chilli intake and the prevalence of obesity. The study adjusted for covariates such as age, sex, ethnicity, educational background, marital status, family income, alcohol intake, physical activity level, diabetes presence, and overall dietary intake, revealing that frequent chilli consumers had significantly higher BMI values by about 0.71 units compared to non-consumers. The most frequent chilli consumers had a 55% greater risk of developing obesity compared to those who did not consume chilli peppers.

Moreover, gender appeared to significantly influence the relationship between chilli intake frequency and BMI, with a more pronounced risk of obesity among female participants and those aged 60 years and older. This finding suggests that frequent intake of chilli could substantially increase BMI and obesity risk in U.S. adults, especially among females. This observation aligns with several large-scale observational studies conducted in Asian countries, where the consumption of chilli peppers is relatively high. It is also hypothesised that chilli peppers are often consumed with high-fat, high-calorie foods, which contribute to unhealthy dietary patterns and weight gain.

Due to the study’s cross-sectional design, it was not possible to establish a causal relationship between chilli intake frequency and obesity risk. Additionally, the survey data did not specify the types of chilli peppers consumed, their spiciness levels, or the exact quantities, which are factors that could potentially influence the association with obesity.

Overall, the findings suggest that reducing the intake of chilli peppers might help mitigate the risk of weight gain and obesity. However, further research, particularly longitudinal studies, is required to explore the complexities of how chilli pepper consumption influences body weight and metabolic health.

High olive oil consumption linked to reduced risk of dementia-related mortality

Recent research highlights a significant association between high olive oil consumption and a decreased risk of mortality due to dementia, regardless of overall diet quality. This insight comes from a prospective study involving over 92,000 participants, suggesting that an intake of at least 7 grams of olive oil daily — approximately half a tablespoon — is linked with a 28% reduction in the risk of dementia-related death.

The research also examined the health benefits of substituting olive oil for more commonly used fats like margarine and mayonnaise. “Replacing one teaspoon of margarine and mayonnaise with the equivalent amount of olive oil was associated with an 8%-14% lower risk for dementia-related mortality,” Anne-Julie Tessier, RD, PhD, from the Department of Nutrition at Harvard T.H. Chan School of Public Health, shared with Medscape Medical News. She emphasised the advantages of opting for natural products like olive oil over more processed fats, highlighting their potential in reducing the risk of fatal dementia. However, Tessier added, “intervention studies are needed to confirm causal effect and optimal quantity of olive oil intake.”

Published on the 6th of May, 2024, in JAMA Network Open, the study leveraged data from the Nurses’ Health Study and the Health Professionals Follow-Up Study, which tracked over 92,000 participants from 1990 to 2018. These individuals, who were free from cardiovascular disease and cancer at the start, were monitored for dietary habits every four years through a food frequency questionnaire and for dementia-related mortality via death records.

The findings showed no interaction by diet quality scores, meaning the reduced risk associated with olive oil consumption occurred independently of overall diet quality. Tessier pointed out that while typically, “people who use olive oil for cooking or as a dressing have an overall better quality of their diet, but interestingly, we found the association between more olive oil and reduced risk of dementia-related death to be regardless of this factor.”

The study acknowledges several limitations, including its observational nature, which makes it challenging to establish cause and effect. “It is also plausible that higher olive oil intake could be indicative of a healthier diet and higher socioeconomic status, although the results remained consistent after accounting for these factors,” the authors noted.

Commenting on the implications of the findings, Rebecca M. Edelmayer, PhD, senior director of scientific engagement for the Alzheimer’s Association, noted the correlation shown by the study but cautioned against drawing causal conclusions. “It would be wonderful if a particular food could delay or prevent Alzheimer’s disease, but we do not have scientific evidence that these claims are true,” Edelmayer commented. She highlighted the necessity for randomised controlled clinical trials to establish whether any foods, including olive oil, have a scientifically proven beneficial effect on cognitive decline and dementia.

This study underscores a promising link between olive oil intake and a reduced risk of dementia-related death, suggesting potential protective benefits. However, further research, particularly interventional studies, is crucial to confirm these observations and understand the underlying mechanisms more fully.